|
Programme(s) to which this project applies: |
| ☑ MPhil/PhD | ☒ MRes[Med] | ☒ URIS |
About the Project
This interdisciplinary research project seeks to transform orthopedic biomaterial development by merging artificial intelligence (AI) with nanotechnology, aiming to design, optimize, and validate next-generation nano-biomaterials for tissue engineering, bacterial infection mitigation, and enhanced regenerative therapies. Traditional biomaterial discovery, which relies on slow, costly trial-and-error methods, will be reimagined through AI's predictive analytics and high-throughput computational modeling. This synergy accelerates the identification of biomaterials with customized properties—including superior biocompatibility, antibacterial efficacy, mechanical resilience, and bioactive functionality—while addressing the limitations of conventional approaches. By harnessing AI's capacity to streamline research and uncover novel solutions, the project not only expedites innovation but also pioneers personalized orthopedic medicine, enabling clinicians to tailor biomaterials to individual patient needs. This paradigm shift promises to elevate surgical outcomes, optimize tissue regeneration, and improve recovery processes, positioning AI-driven nanotechnology as a cornerstone of advanced orthopedics. The integration of these technologies will redefine biomaterial development, fostering breakthroughs that bridge computational precision with clinical practicality for transformative patient care.
About the Supervisor
Professor KWK Yeung, Department of Orthopaedics and Traumatology
Professor Kelvin Yeung, who has been endowed by Ng Chun-Man Professorship in Orthopaedic Bioengineering, serves as a tenured full professor, chief of the research division, and departmental research and postgraduate advisor in the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine (HKUMed), at The University of Hong Kong. He is a renowned orthopedic biomaterial researcher, focusing on antibacterial coatings, 3D bio-printing, and musculoskeletal tissue engineering. His impressive h-index (Scopus) is 83, with over 25,000 citations and 91 (Google Scholar) with 29,000 citations and an i10-index of 271. He has been recognized as one of the Highly Cited Researchers 2023 and 2024 (cross-field), Highly Ranked Scholar 2022 (Prior Five Years) in the field of Medicine by ScholarGPS (Global ranking: #7 in Biomaterial; #14 in Antibacterial activity; #16 in Orthopaedic Surgery), Top Cited Scholar 2024, ranking among the Top 1% Scholars Worldwide in the field of biomaterials by Clarivate Analytics' Essential Science Indicators (ESI) and among the World's Top 2% Scientists in standardized citation indicators (Biomedical Engineering) since 2014. In 2024, he ranked #1845 globally and #483 in China under the category of materials science (Research.com). In 2024, he was elected as a Lifetime Fellow of the International Association of Advanced Materials.
Next Step?
For more information or to express interest for this project, please email the supervisor or the specified contact point in the project description. Interested candidates are advised to enclose with your email:
- your CV,
- a brief description of your research interest and experience, and
- two reference letters (not required for HKUMed UG students seeking MRes[Med]/URIS projects).
Information on the research programme, funding support and admission documentations could be referenced online at the Research Postgraduate Admissions website. General admission enquiries should be directed to rpgmed@hku.hk.
HKUMed MBBS students interested in the Master of Research in Medicine (MRes[Med]) programme may visit the programme website for more information.
HKUMed UG students interested in the Undergraduate Research Internship Scheme (URIS) may visit the scheme’s website for more information.
Follow HKUMed